Purkinje-Related Ventricular Tachycardia and Ventricular Fibrillation
JACC: Clinical Electrophysiology · 2023
DOI: 10.1016/j.jacep.2023.05.040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Clinical Electrophysiology, 2023. Verfasst von Akihiko Nogami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; Institute of Arrhythmia, Tokyo Heart Rhythm Hospital, Tokyo, …. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Ventricular Premature Complexes. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Of the monomorphic ventricular tachycardias, there are 4 specific tachycardias related to the Purkinje system: 1) idiopathic verapamil-sensitive fascicular ventricular tachycardia (FVT); 2) non-re-entrant FVT; 3) bundle branch re-entry and interfascicular re-entry; and 4) Purkinje-mediated VT in structural heart disease. Verapamil-sensitive FVT is classified into 4 types according to the location of the circuit: 1) left posterior type; 2) left anterior type; 3) left upper septal type;and 4) reverse type. And, in the left anterior and posterior types, there are septal and papillary muscle subtypes. Although macro-re-entry has been reported to be the mechanism underlying verapamil-sensitive FVT, recording the entire circuit is challenging. One possible reason is that the Purkinje-muscle junction may penetrate the myocardial layer as a part of the circuit. The Purkinje network may thus play an important role in the initiation and maintenance of ventricular fibrillation. Further, it has been reported that the development and the abnormalities of the Purkinje system are associated with the arrhythmogenesis of ventricular fibrillation. Furthermore, it has been reported that catheter ablation of trigger ventricular premature complexes, and/or "de-networking" of the Purkinje system, can be used as electrical bailout therapy. There is a hypothesis that the intramural Purkinje system is involved in the generation of J waves. Nevertheless, as there are still unresolved issues that must be debated and accurately analyzed, this review aims to discuss the solved and unsolved questions related to Purkinje-related arrhythmias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; Institute of Arrhythmia, Tokyo Heart Rhythm Hospital, Tokyo, Japan. Electronic address: akihiko-ind@umin.ac.jp.
- Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
- Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; Faculty of Medicine, University of Kufa, Najaf, Iraq.
- Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; Cardiac Electrophysiology Unit, Division of Cardiology, Central Chest Institute of Thailand, Nonthaburi, Thailand.
- Cardiovascular Center, Medical Research Institute Kitano Hospital, Osaka, Japan.
- Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Zitieren
APA
Nogami, A., Komatsu, Y., Talib, A. K., Phanthawimol, W., Naeemah, Q. J., Haruna, T., & Morishima, I. (2023). Purkinje-Related Ventricular Tachycardia and Ventricular Fibrillation. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2023.05.040
Vancouver
Nogami A, Komatsu Y, Talib AK, Phanthawimol W, Naeemah QJ, Haruna T, et al. Purkinje-Related Ventricular Tachycardia and Ventricular Fibrillation. JACC: Clinical Electrophysiology. 2023. doi:10.1016/j.jacep.2023.05.040
BibTeX
@article{Nogami2023,
author = {Nogami, Akihiko and Komatsu, Yuki and Talib, Ahmed Karim and Phanthawimol, Wipat and Naeemah, Qasim J and Haruna, Tetsuya and Morishima, Itsuro},
title = {Purkinje-Related Ventricular Tachycardia and Ventricular Fibrillation},
journal = {JACC: Clinical Electrophysiology},
year = {2023},
doi = {10.1016/j.jacep.2023.05.040}
}
EUVIMED